Effect of continuous positive airway pressure on leptin levels in patients with obstructive sleep apnea: A meta-analysis

Otolaryngology - Head and Neck Surgery (United States)

Volumn 152, Issue 4, 2015, Pages 610-618

  Chen, Xiong ^a   Niu, Xun ^a   Xiao, Ying ^a   Dong, Jiaqi ^a   Lu, Meixia ^a   Kong, Weijia ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

continuous positive airway pressure; insulin resistance; leptin; meta analysis; obesity; obstructive sleep apnea

Indexed keywords

LEPTIN; DNA BINDING PROTEIN; INSULIN RESPONSE ELEMENT BINDING PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

APNEA HYPOPNEA INDEX; BODY MASS; FOLLOW UP; HORMONE BLOOD LEVEL; HUMAN; LONG TERM CARE; META ANALYSIS; POSITIVE END EXPIRATORY PRESSURE; PUBLISHING; REVIEW; SENSITIVITY ANALYSIS; SHORT COURSE THERAPY; SLEEP DISORDERED BREATHING; BLOOD; SLEEP APNEA, OBSTRUCTIVE; WEIGHT REDUCTION;

CONTINUOUS POSITIVE AIRWAY PRESSURE; DNA-BINDING PROTEINS; HUMANS; LEPTIN; SLEEP APNEA, OBSTRUCTIVE; TRANSCRIPTION FACTORS; WEIGHT LOSS;

EID: 84926324810     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599814562719     Document Type: Review

References (60)

1. Ryan CM, Bradley TD. Pathogenesis of obstructive sleep apnea. J Appl Physiol (1985). 2005; 99: 2440-2450
2. Xiao Y, Chen X, Shi H, et al. Evaluation of airway obstruction at soft palate level in male patients with obstructive sleep apnea/hypopnea syndrome: dynamic 3-dimensional CT imaging of upper airway. J Huazhong Univ Sci Technolog Med Sci. 2011; 31: 413-418
3. Peppard PE, Young T, Barnet JH, et al. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. 2013; 177: 1006-1014
4. Marik PE. Leptin, obesity, and obstructive sleep apnea. Chest. 2000; 118: 569-571
5. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature. 1998; 395: 763-770
6. Fruhbeck G, Jebb SA, Prentice AM. Leptin: physiology and pathophysiology. Clin Physiol. 1998; 18: 399-419
7. Sanders MH. Article reviewed: serum leptin and vascular risk factors in obstructive sleep apnea. Sleep Med. 2001; 2: 161-163
8. Yee BJ, Cheung J, Phipps P, et al. Treatment of obesity hypoventilation syndrome and serum leptin. Respiration. 2006; 73: 209-212
9. Harsch IA, Konturek PC, Koebnick C, et al. Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment. Eur Respir J. 2003; 22: 251-257
10. Drummond M, Winck JC, Guimaraes JT, et al. Autoadjusting-CPAP effect on serum leptin concentrations in obstructive sleep apnoea patients. BMC Pulm Med. 2008; 8: 21
11. Manzella D, Parillo M, Razzino T, et al. Soluble leptin receptor and insulin resistance as determinant of sleep apnea. Int J Obes Relat Metab Disord. 2002; 26: 370-375
12. Harsch IA, Schahin SP, Bruckner K, et al. The effect of continuous positive airway pressure treatment on insulin sensitivity in patients with obstructive sleep apnoea syndrome and type 2 diabetes. Respiration. 2004; 71: 252-259
13. Aizawa-Abe M, Ogawa Y, Masuzaki H, et al. Pathophysiological role of leptin in obesity-related hypertension. J Clin Invest. 2000; 105: 1243-1252
14. Konstantinides S, Schafer K, Koschnick S, et al. Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity. J Clin Invest. 2001; 108: 1533-1540
15. Cuhadaroglu C, Utkusavas A, Ozturk L, et al. Effects of nasal CPAP treatment on insulin resistance, lipid profile, and plasma leptin in sleep apnea. Lung. 2009; 187: 75-81
16. Kieffer TJ, Heller RS, Habener JF. Leptin receptors expressed on pancreatic beta-cells. Biochem Biophys Res Commun. 1996; 224: 522-527
17. Piatti P, Di Mario C, Monti LD, et al. Association of insulin resistance, hyperleptinemia, and impaired nitric oxide release with in-stent restenosis in patients undergoing coronary stenting. Circulation. 2003; 108: 2074-2081
18. Yatagai T, Nagasaka S, Taniguchi A, et al. Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. Metabolism. 2003; 52: 1274-1278
19. Harsch IA, Schahin SP, Radespiel-Troger M, et al. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 2004; 169: 156-162
20. Malhotra A, Ayas NT, Epstein LJ. The art and science of continuous positive airway pressure therapy in obstructive sleep apnea. Curr Opin Pulm Med. 2000; 6: 490-495
21. West SD, Kohler M, Nicoll DJ, et al. The effect of continuous positive airway pressure treatment on physical activity in patients with obstructive sleep apnoea: a randomised controlled trial. Sleep Med. 2009; 10: 1056-1058
22. Tsara V, Kaimakamis E, Serasli E, et al. Health related quality of life in Greek patients with sleep apnea-hypopnea syndrome treated with continuous positive airway pressure. Sleep Med. 2009; 10: 217-225
23. D'Ambrosio C, Bowman T, Mohsenin V. Quality of life in patients with obstructive sleep apnea: effect of nasal continuous positive airway pressure-a prospective study. Chest. 1999; 115: 123-129
24. Goncalves MA, Guilleminault C, Ramos E, et al. Erectile dysfunction, obstructive sleep apnea syndrome and nasal CPAP treatment. Sleep Med. 2005; 6: 333-339
25. Garcia JM, Sharafkhaneh H, Hirshkowitz M, et al. Weight and metabolic effects of CPAP in obstructive sleep apnea patients with obesity. Respir Res. 2011; 12: 80
26. Macrea MM, Martin TJ, Zagrean L. Infertility and obstructive sleep apnea: the effect of continuous positive airway pressure therapy on serum prolactin levels. Sleep Breath. 2010; 14: 253-257
27. Barcelo A, Barbe F, Llompart E, et al. Neuropeptide Y and leptin in patients with obstructive sleep apnea syndrome: role of obesity. Am J Respir Crit Care Med. 2005; 171: 183-187
28. Huang R, Huang XZ, Wang HG, et al. [Effects of nasal continuous positive airway pressure on serum leptin concentration and the metabolic parameters in obstructive sleep apnea hypopnea syndrome]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2004; 26: 168-171
29. Sanner BM, Kollhosser P, Buechner N, et al. Influence of treatment on leptin levels in patients with obstructive sleep apnoea. Eur Respir J. 2004; 23: 601-604
30. Chin K, Nakamura T, Takahashi K, et al. Effects of obstructive sleep apnea syndrome on serum aminotransferase levels in obese patients. Am J Med. 2003; 114: 370-376
31. Chin K, Shimizu K, Nakamura T, et al. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation. 1999; 100: 706-712
32. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959; 22: 719-478
33. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 200221: 1539-1558
34. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003; 327: 557-560
35. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986; 7: 177-188
36. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315: 629-634
37. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994; 50: 1088-1101
38. Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000; 56: 455-463
39. Hoyos CM, Killick R, Yee BJ, et al. Cardiometabolic changes after continuous positive airway pressure for obstructive sleep apnoea: a randomised sham-controlled study. Thorax. 2012; 67: 1081-1089
40. Sanchez-de-la-Torre M, Mediano O, Barcelo A, et al. The influence of obesity and obstructive sleep apnea on metabolic hormones. Sleep Breath. 2012; 16: 649-656
41. Tasali E, Chapotot F, Leproult R, et al. Treatment of obstructive sleep apnea improves cardiometabolic function in young obese women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2011; 96: 365-374
42. Yamamoto Y, Fujiuchi S, Hiramatsu M, et al. Resistin is closely related to systemic inflammation in obstructive sleep apnea. Respiration. 2008; 76: 377-385
43. Harsch IA, Koebnick C, Wallaschofski H, et al. Resistin levels in patients with obstructive sleep apnoea syndrome-the link to subclinical inflammation?. Med Sci Monit. 2004; 10 :
44. Kumor M, Bielicki P, Przybylowski T, et al. [Three month continuous positive airway pressure (CPAP) therapy decreases serum total and LDL cholesterol, but not homocysteine and leptin concentration in patients with obstructive sleep apnea syndrome (OSAS)]. Pneumonol Alergol Pol. 2011; 79: 173-183
45. Rubinsztajn R, Kumor M, Byskiniewicz K, et al. [The influence of 3 weeks therapy with continuous positive airway pressure on serum leptin and homocysteine concentration in patients with obstructive sleep apnea syndrome]. Pneumonol Alergol Pol. 2006; 74: 63-67
46. Petrisor BA, Keating J, Schemitsch E. Grading the evidence: levels of evidence and grades of recommendation. Injury. 2006; 37: 321-327
47. Vgontzas AN, Tan TL, Bixler EO, et al. Sleep apnea and sleep disruption in obese patients. Arch Intern Med. 1994; 154: 1705-1711
48. Richman RM, Elliott LM, Burns CM, et al. The prevalence of obstructive sleep apnoea in an obese female population. Int J Obes Relat Metab Disord. 1994; 18: 173-177
49. Moraes W, Poyares D, Zalcman I, et al. Association between body mass index and sleep duration assessed by objective methods in a representative sample of the adult population. Sleep Med. 2013; 14: 312-318
50. Malhotra A, White DP. Obstructive sleep apnoea. Lancet. 2002; 360: 237-245
51. Maffei M, Halaas J, Ravussin E, et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med. 1995; 1: 1155-1161
52. Van Cauter E, Spiegel K, Tasali E, et al. Metabolic consequences of sleep and sleep loss. Sleep Med. 2008; 9: S23-S28
53. Somers VK, Dyken ME, Clary MP, et al. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest. 1995; 96: 1897-1904
54. Snitker S, Pratley RE, Nicolson M, et al. Relationship between muscle sympathetic nerve activity and plasma leptin concentration. Obes Res. 1997; 5: 338-340
55. Saladin R, De Vos P, Guerre-Millo M, et al. Transient increase in obese gene expression after food intake or insulin administration. Nature. 1995; 377: 527-529
56. Manyari DE, Wang Z, Cohen J, et al. Assessment of the human splanchnic venous volume-pressure relation using radionuclide plethysmography: effect of nitroglycerin. Circulation. 1993; 87: 1142-1151
57. Esler M, Vaz M, Collier G, et al. Leptin in human plasma is derived in part from the brain, and cleared by the kidneys. Lancet. 1998; 351: 879
58. Kapsimalis F, Varouchakis G, Manousaki A, et al. Association of sleep apnea severity and obesity with insulin resistance, C-reactive protein, and leptin levels in male patients with obstructive sleep apnea. Lung. 2008; 186: 209-217
59. Friedman M, Samuelson CG, Hamilton C, et al. Effect of continuous positive airway pressure on C-reactive protein levels in sleep apnea: a meta-analysis. Otolaryngol Head Neck Surg. 2012; 147: 4234-4233
60. Guo Y, Pan L, Ren D, et al. Impact of continuous positive airway pressure on C-reactive protein in patients with obstructive sleep apnea: a meta-analysis. Sleep Breath. 2013; 17: 495-503